Savient Pharmaceuticals Inc (SVNT) Return on Investment ROI from the third quarter of 2013 to third quarter of 2012 and for the year 2013, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Savient Pharmaceuticals Inc  (SVNT)


Savient Pharmaceuticals Inc's ROI from its third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Savient Pharmaceuticals Inc's ROI in the third quarter of 2013?
Savient Pharmaceuticals Inc recorded a cumulative net loss of $-98 million during 12 months ending in the third quarter of 2013, resulting in a negative return on investment (ROI) of -38.75%.

Within the Healthcare sector 231 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2013 from 1264 to 1469.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Investment Change TTM 82.61 % 0.12 % -2.69 % -48.62 % -31.35 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 423 48 457 88 110
Return On Investment (TTM) -38.75 % -67.05 % -54.45 % -99.32 % -64.96 %
SVNT's Overall Ranking # 1469 # 1264 # 0 # 0 #
Seq. Investment Change TTM 44.68 % -12.01 % 67.37 % -14.29 % -20.68 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -98 -118 -109 -118 -90

SVNT Company Profile >> Back to SVNT Roi Comparisons >> See Annual SVNT Return On Investment



Return On Investment SVNT's Ranking
Within: No.
Industry # 33
Sector # 232
Overall # 1469

Return On Investment Statistics
High Average Low
-99.32 %
-106.11 %
-112.9 %
(Dec 31 2012)   (Jun 30 2013)







Financial Statements
Savient Pharmaceuticals Inc's III. Quarter Investments $ 423 Millions SVNT's Balance sheet
Savient Pharmaceuticals Inc's III. Quarter Income $ -20 Millions Quarterly SVNT's Income Statement
SVNT's Income by Division See SVNT's Income by Division


SVNT Annual Return On Investment (Dec 31 2012)
2012		 (Dec 31 2011)
2011		 (Dec 31 2008)
2010

Total Investments in Millions 88 167 64 0 0
Y / Y Investment Growth -47.57 % 160.21 % - - -
Net Income in Millions -118 -102 -84 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -135.07 % -61.08 % -131.11 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SVNT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SVNT's Competitors
Subscribers only: Roi for Savient Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for SVNT's Customers

Other Ratios
SVNT's Roa SVNT's Inventory Turnover Ratio SVNT's Growth Rates SVNT's Dividend Statistics
SVNT's Profitability Ratios SVNT's Asset Turnover Ratio SVNT's Dividend Growth
SVNT's Roe SVNT's Valuation Ratios SVNT's Financial Strength Ratios SVNT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2013, within Healthcare Sector ROI

Date modified: 2026-09-02T17:38:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.